0000905148-23-000513.txt : 20230726 0000905148-23-000513.hdr.sgml : 20230726 20230726181836 ACCESSION NUMBER: 0000905148-23-000513 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230724 FILED AS OF DATE: 20230726 DATE AS OF CHANGE: 20230726 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vazquez Chris CENTRAL INDEX KEY: 0001980594 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39659 FILM NUMBER: 231114865 MAIL ADDRESS: STREET 1: 2970 WILDERNESS PLACE STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIODESIX INC CENTRAL INDEX KEY: 0001439725 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 203986492 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2970 WILDERNESS PLACE STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 303-417-0500 MAIL ADDRESS: STREET 1: 2970 WILDERNESS PLACE STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 4 1 form4.xml X0508 4 2023-07-24 0001439725 BIODESIX INC BDSX 0001980594 Vazquez Chris 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301 true Chief Accounting Officer false Stock Options (Right to buy) 20.67 2023-07-24 4 D 0 16000 D 2031-02-22 Common Stock 16000 0 D Stock Options (Right to buy) 1.2 2023-07-24 4 A 0 3266 A 2033-07-23 Common Stock 3266 3266 D Stock Options (Right to buy) 1.2 2023-07-24 4 A 0 25000 0 A 2033-07-23 Common Stock 25000 25000 D This option vested 40% on February 23, 2023, and the remaining 60% were scheduled to vest in 36 successive, equal monthly installments measured from February 23, 2023. On June 23, 2023, the Issuer made an offer (the "Tender Offer") to certain employees to exchange some or all of their outstanding options with an exercise price greater than $10.00 per share (such options properly tendered for exchange, "Surrendered Options") for new options with terms determined in accordance with the terms of the Tender Offer ("Replacement Options"). The Tender Offer closed on July 24, 2023, and the Issuer's board of directors approved the exchange of Surrendered Options for Replacement Options on July 24, 2023. The Reporting Person elected to participate in the Tender Offer and received 3,266 Replacement Options with an exercise price of $1.20 per share in exchange for 16,000 Surrendered Options with an exercise price of $20.67 per share, after which the Surrendered Options were cancelled. This Replacement Option vests as follows: 1,579 shares of Common Stock underlying this Replacement Option vest on August 1, 2024, and the remaining 1,687 shares of Common Stock underlying this Replacement Option vest in 31 successive, equal monthly installments beginning on August 1, 2024. This option vests in a series of 48 successive, equal monthly installments measured from July 24, 2023, subject to the Reporting Person's continuous service through each applicable vesting date. /s/ Robin H. Cowie as Attorney-in-Fact for Chris Vazquez 2023-07-26